18F-DOPA PET Imaging: an Evaluation of Biodistribution and Safety Trial Phase 3 Completed Jan. 9, 2022
BUrst vs. Spaced Physical Therapy for Parkinson's Disease: The BUS PT Timing Trial Trial N/A Completed Jan. 5, 2022
Attending to External Cues and Movement Strategies in Parkinson Disease Trial N/A Completed Jan. 3, 2022
Study on the Safety, Tolerance and Pharmacokinetics of Phenlarmide Tablets Trial Phase 1 Completed Jan. 2, 2022
Umbilical Cord Derived Mesenchymal Stem Cells Therapy in Parkinson's Disease Trial Phase 1 Unknown Dec. 29, 2021
A Training of the Rhythmic Skills With a Serious Game to Improve Gait and Cognitive Abilities in Parkinson's Disease Trial N/A Suspended Dec. 28, 2021
Clinical Correlates of COVID-19 Pandemic in Patients With Functional Movement Disorder (FMD) and Parkinson's Disease (PD) Trial N/A Completed Dec. 21, 2021
The Effect of Repetitive Transcranial Magnetic Stimulation on Cognitive Impairment in Parkinson's Disease (PD) Trial N/A Completed Dec. 20, 2021
Evaluation of Using Vibrotactile Coordinated Reset for Management of Parkinson's Disease Trial N/A Terminated Dec. 20, 2021
A Study to Evaluate the Safety and Tolerability of ABBV-0805 in Patients With Parkinson's Disease Trial Phase 1 Withdrawn Dec. 14, 2021
Observational Study Evaluating Long-Term Effectiveness of Duodopa/Duopa in Patients With Advanced Parkinson's Disease Trial N/A Completed Dec. 14, 2021
A Single-dose Study to Investigate the Tolerance and Pharmacokinetics of Finamine Tablets in China Trial Phase 1 Completed Dec. 13, 2021